Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Social isolation may be an early indicator of increased dementia risk

Social isolation is linked to lower brain volume in areas related to cognition and a higher risk of dementia, according to research published in the June 8, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

8 Jun 2022

USC scientists receive more than $16 million to study the role of blood vessel dysfunction in Alzheimer’s disease

The National Institute on Aging, a division of the National Institutes of Health, awarded Berislav Zlokovic, MD, PhD, director of the Zilkha Neurogenetic Institute, and Arthur W. Toga, PhD, director of the USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI), $16.1 million to continue research on the role that blood vessel dysfunction plays in the development of dementia and Alzheimer's disease.

7 Jun 2022

Oral administration of rapamycin increases β-amyloid buildup in Alzheimer's disease mouse model

Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have found that oral administration of rapamycin to an Alzheimer's disease mouse model causes an increase in beta (β)-amyloid protein plaques. β-amyloid buildup is a hallmark of Alzheimer's disease.

7 Jun 2022

Age exacerbates COVID neuroimmunological symptoms

In a recent study posted to the bioRxiv* pre-print server, researchers at the University of Illinois at Chicago investigated whether aging exacerbated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-induced neuropsychiatric disorders.

6 Jun 2022

Addressing the ‘trust factor’: South Carolina researchers tackle health disparities using genetics

Quenton Tompkins' family tree is deeply rooted in rural McCormick County, South Carolina.

6 Jun 2022

Researchers repurpose a cancer drug for the treatment of neuroinflammatory diseases

The repurposing of FDA-approved drugs for alternative diseases is a faster way of bringing new treatments into the clinic.

3 Jun 2022

Diabetes drug's target protein can be a candidate for the treatment of Alzheimer's disease

Mechanisms associated with a particular diabetes drug can also help to protect against Alzheimer's disease, a study by researchers at Karolinska Institutet in Sweden and published in Neurology reports.

3 Jun 2022

Truncated tau protein may be a means for better diagnosis and treatment of Alzheimer's disease

In a new study of Alzheimer's disease, researchers at UC San Francisco have discovered that a relatively unstudied form of the tau protein associated with neurodegeneration may be a means for better diagnosis and treatment of the disease.

2 Jun 2022

New study in mice shows alternate origins of plaques in Alzheimer’s disease

A breakdown in how brain cells rid themselves of waste precedes the buildup of debris-filled plaques known to occur in Alzheimer's disease, a new study in mice shows.

2 Jun 2022

KHN’s ‘What the Health?’: Washington’s slow churn

In the wake of three high-profile mass shootings in less than a month, lawmakers on Capitol Hill have renewed negotiations over legislation that could stem gun violence.

2 Jun 2022

New SOL-INCA-AD grant extends the initial study to examine cognitive aging among Latinos

Researchers at University of California San Diego School of Medicine have received a $24.5 million grant from the National Institutes of Health (NIH)/National Institute on Aging (NIA) to continue the Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA), a 12-year assessment of cognitive and brain aging and impairment among aging Latinos.

1 Jun 2022

Stem cell model could provide insights into biological mechanisms that underlie neuropsychiatric disorders

Researchers from the Icahn School of Medicine at Mount Sinai have applied a novel stem cell model to map disease risk variants in human neurons, which could help provide insights into the biological mechanisms that underlie neuropsychiatric disorders such as autism and schizophrenia.

1 Jun 2022

Ultrasound localization microscopy can image microscopic vessels and measure blood flow in the brain

To image microscopic vessels and measure blood flow in the brain, researchers use a tool called ultrasound localization microscopy. It works by using microscopic bubbles circulated through the bloodstream as a contrast agent to measure the reflection of high-frequency acoustic waves passing through the body.

1 Jun 2022

Dementia diagnosis can also make a big difference in health care costs

Getting diagnosed with Alzheimer's disease or another kind of dementia is never pleasant – but a new study shows that when and how someone's cognitive issues come to light can also make a big difference in their health care costs.

31 May 2022

Physicians should have rudimentary knowledge of the benefits of plant-based diet for six health conditions

A new commentary in the American Journal of Lifestyle Medicine says that all physicians should be aware of the benefits of a plant-based diet for six health conditions: weight loss and maintenance, cardiovascular disease, cancer, diabetes, Alzheimer's disease, and COVID-19.

31 May 2022

Study aims to analyze Alzheimer's patients' ability to process contextual information from the face

In recent years Alzheimer's disease has been on the rise throughout the world and is rarely diagnosed at an early stage when it can still be effectively controlled.

31 May 2022

New approach to quantify cognitive decline in dogs could aid in the treatment of humans with Alzheimer’s

Researchers have found that a suite of complementary tests can quantify changes in dogs suspected of suffering from cognitive decline.

30 May 2022

Study evaluates diagnostic performance of two blood-based biomarkers specific to Alzheimer's disease

A simple blood test to diagnose Alzheimer's disease, perhaps even years before symptoms appear, is an exciting possibility, but a new study shows that much more research is needed before these blood tests are routinely used in the clinical diagnostic setting.

26 May 2022

Researchers receive $8 million grant to prevent traumatic brain injury in military personnel

Researchers backed by an $8 million U.S. Department of Defense grant will explore how to better prevent traumatic brain injury, or TBI, in military personnel exposed to blast shock waves.

26 May 2022

Size of air pollution particles may affect a person's risk of dying from stroke, study finds

Living in areas with higher air pollution is associated with an increased risk of in-hospital death from stroke, and the risk varies depending on the size of the air pollution particles, according to a new study published in the May 25, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

25 May 2022

Alzheimer's Disease News and Research

Further Reading

Social isolation may be an early indicator of increased dementia risk

USC scientists receive more than $16 million to study the role of blood vessel dysfunction in Alzheimer’s disease

Oral administration of rapamycin increases β-amyloid buildup in Alzheimer's disease mouse model

Age exacerbates COVID neuroimmunological symptoms

Addressing the ‘trust factor’: South Carolina researchers tackle health disparities using genetics

Researchers repurpose a cancer drug for the treatment of neuroinflammatory diseases

Diabetes drug's target protein can be a candidate for the treatment of Alzheimer's disease

Truncated tau protein may be a means for better diagnosis and treatment of Alzheimer's disease

New study in mice shows alternate origins of plaques in Alzheimer’s disease

KHN’s ‘What the Health?’: Washington’s slow churn

New SOL-INCA-AD grant extends the initial study to examine cognitive aging among Latinos

Stem cell model could provide insights into biological mechanisms that underlie neuropsychiatric disorders

Ultrasound localization microscopy can image microscopic vessels and measure blood flow in the brain

Dementia diagnosis can also make a big difference in health care costs

Physicians should have rudimentary knowledge of the benefits of plant-based diet for six health conditions

Study aims to analyze Alzheimer's patients' ability to process contextual information from the face

New approach to quantify cognitive decline in dogs could aid in the treatment of humans with Alzheimer’s

Study evaluates diagnostic performance of two blood-based biomarkers specific to Alzheimer's disease

Researchers receive $8 million grant to prevent traumatic brain injury in military personnel

Size of air pollution particles may affect a person's risk of dying from stroke, study finds

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News